Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMYMP) Intangibles (2016 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed Intangibles for 17 consecutive years, with $19.1 billion as the latest value for Q4 2025.

  • Quarterly Intangibles fell 18.04% to $19.1 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $19.1 billion through Dec 2025, down 18.04% year-over-year, with the annual reading at $19.1 billion for FY2025, 18.04% down from the prior year.
  • Intangibles for Q4 2025 was $19.1 billion at Bristol Myers Squibb, down from $20.5 billion in the prior quarter.
  • The five-year high for Intangibles was $50.8 billion in Q1 2021, with the low at $19.1 billion in Q4 2025.
  • Average Intangibles over 5 years is $32.7 billion, with a median of $32.0 billion recorded in 2023.
  • The sharpest move saw Intangibles decreased 2.41% in 2024, then tumbled 31.36% in 2025.
  • Over 5 years, Intangibles stood at $42.5 billion in 2021, then decreased by 15.68% to $35.9 billion in 2022, then fell by 24.5% to $27.1 billion in 2023, then fell by 13.91% to $23.3 billion in 2024, then fell by 18.04% to $19.1 billion in 2025.
  • According to Business Quant data, Intangibles over the past three periods came in at $19.1 billion, $20.5 billion, and $21.4 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.